HIV vaccine race: which shot schedule wins?
NCT ID NCT00490074
First seen Apr 25, 2026 · Last updated May 22, 2026 · Updated 4 times
Summary
This study tested two different schedules of an experimental HIV vaccine in 147 healthy adults to see which one triggers a stronger immune response. Volunteers received either three doses of a DNA vaccine followed by one booster, or two doses of DNA followed by two boosters. The goal was to find a safe and effective way to train the body to fight HIV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Hospitalier Universitaire Vaudois CHUV
Lausanne, 1011, Switzerland
-
Hôpital Henri Mondor
Créteil, 94010, France
Conditions
Explore the condition pages connected to this study.